PAWR

For the airport in Alaska using the ICAO location indicator PAWR, see Whittier Airport.
PAWR
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
Aliases PAWR, Pawr, 2310001G03Rik, PAR4, Par-4, pro-apoptotic WT1 regulator
External IDs MGI: 2149961 HomoloGene: 1940 GeneCards: PAWR
Genetically Related Diseases
attention deficit hyperactivity disorder, Conduct disorder[1]
RNA expression pattern




More reference expression data
Orthologs
Species Human Mouse
Entrez

5074

114774

Ensembl

ENSG00000177425

ENSMUSG00000035873

UniProt

Q96IZ0

Q925B0

RefSeq (mRNA)

NM_002583

NM_054056

RefSeq (protein)

NP_002574.2

NP_473397.1

Location (UCSC) Chr 12: 79.57 – 79.69 Mb Chr 10: 108.33 – 108.41 Mb
PubMed search [2] [3]
Wikidata
View/Edit HumanView/Edit Mouse

PRKC, apoptosis, WT1, regulator, also known as PAWR or Prostate apoptosis response-4 (Par-4), is a human gene coding for a tumor-suppressor protein that induces apoptosis in cancer cells, but not in normal cells.

Function

The tumor suppressor WT1 represses and activates transcription. The protein encoded by this gene is a WT1-interacting protein that itself functions as a transcriptional repressor. It contains a putative leucine zipper domain which interacts with the zinc finger DNA binding domain of WT1. This protein is specifically upregulated during apoptosis of prostate cells.[4] The active domain of the Par-4 protein has been found to confer cancer resistance in transgenic mice without compromising normal viability or aging, and may have therapeutic significance.[5]

Interactions

PAWR has been shown to interact with:

References

  1. "Diseases that are genetically associated with PAWR view/edit references on wikidata".
  2. "Human PubMed Reference:".
  3. "Mouse PubMed Reference:".
  4. "Entrez Gene: PAWR PRKC, apoptosis, WT1, regulator".
  5. Zhao Y, Burikhanov R, Qiu S, Lele SM, Jennings CD, Bondada S, Spear B, Rangnekar VM (Oct 2007). "Cancer resistance in transgenic mice expressing the SAC module of Par-4". Cancer Research. 67 (19): 9276–85. doi:10.1158/0008-5472.CAN-07-2124. PMID 17909035.
  6. Guo Q, Xie J (Feb 2004). "AATF inhibits aberrant production of amyloid beta peptide 1-42 by interacting directly with Par-4". The Journal of Biological Chemistry. 279 (6): 4596–603. doi:10.1074/jbc.M309811200. PMID 14627703.
  7. Kawai T, Akira S, Reed JC (Sep 2003). "ZIP kinase triggers apoptosis from nuclear PML oncogenic domains". Molecular and Cellular Biology. 23 (17): 6174–86. doi:10.1128/mcb.23.17.6174-6186.2003. PMC 180930Freely accessible. PMID 12917339.
  8. Díaz-Meco MT, Municio MM, Frutos S, Sanchez P, Lozano J, Sanz L, Moscat J (Sep 1996). "The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C". Cell. 86 (5): 777–86. doi:10.1016/s0092-8674(00)80152-x. PMID 8797824.
  9. Xie J, Guo Q (Jul 2004). "Par-4 inhibits choline uptake by interacting with CHT1 and reducing its incorporation on the plasma membrane". The Journal of Biological Chemistry. 279 (27): 28266–75. doi:10.1074/jbc.M401495200. PMID 15090548.
  10. Roussigne M, Cayrol C, Clouaire T, Amalric F, Girard JP (Apr 2003). "THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies". Oncogene. 22 (16): 2432–42. doi:10.1038/sj.onc.1206271. PMID 12717420.
  11. Johnstone RW, See RH, Sells SF, Wang J, Muthukkumar S, Englert C, Haber DA, Licht JD, Sugrue SP, Roberts T, Rangnekar VM, Shi Y (Dec 1996). "A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1". Molecular and Cellular Biology. 16 (12): 6945–56. doi:10.1128/mcb.16.12.6945. PMC 231698Freely accessible. PMID 8943350.

Further reading

This article is issued from Wikipedia - version of the 5/20/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.